4 free views remaining today
autosomal dominant nonsyndromic deafness 47
ICD-10 Codes
Related ICD-10:
Description
Autosomal dominant nonsyndromic deafness refers to a type of hearing loss that is inherited in an autosomal dominant pattern, meaning that only one copy of the mutated gene is needed to express the condition. This form of deafness typically affects both ears and tends to be bilateral.
- Characteristics of autosomal dominant non-syndromic HL are heterogenous [4].
- In most cases, HL tends to be bilateral, post-lingual in onset (childhood or later) [4].
- Autosomal dominant deafness often results from inheriting an altered copy of the gene from a parent who has hearing loss [8].
Autosomal dominant nonsyndromic deafness can manifest at various ages, but it typically becomes apparent during childhood or adulthood. The condition is characterized by progressive sensorineural hearing loss, which means that the inner ear's ability to detect sound is impaired.
- Autosomal dominant deafness-9 (DFNA9) is an adult-onset form of progressive sensorineural hearing loss associated with variable vestibular dysfunction [5].
- An autosomal dominant nonsyndromic deafness that is characterized postlingual onset in the second decade of life with flat progressive hearing loss and has been reported [7].
It's worth noting that the frequency of autosomal dominant deafness varies, but it is generally considered to be less common than autosomal recessive deafness. According to some reports, autosomal dominant deafness accounts for approximately 20% of nonsyndromic deafness cases [9].
Additional Characteristics
- Autosomal dominant nonsyndromic deafness refers to a type of hearing loss that is inherited in an autosomal dominant pattern, meaning that only one copy of the mutated gene is needed to express the condition.
- This form of deafness typically affects both ears and tends to be bilateral.
- Autosomal dominant deafness often results from inheriting an altered copy of the gene from a parent who has hearing loss.
- The condition is characterized by progressive sensorineural hearing loss, which means that the inner ear's ability to detect sound is impaired.
- It's worth noting that the frequency of autosomal dominant deafness varies, but it is generally considered to be less common than autosomal recessive deafness.
Signs and Symptoms
Autosomal dominant nonsyndromic deafness 47 (DFNA47) is a genetic disorder that affects hearing. The signs and symptoms of DFNA47 are not well-documented, but based on the available information, here are some possible characteristics:
- Bilateral hearing loss: Hearing loss in both ears is a common feature of autosomal dominant nonsyndromic deafness 47.
- Post-lingual onset: The hearing loss typically begins after language development has occurred, which means that individuals with DFNA47 may have developed speech and language skills before experiencing hearing difficulties.
- Gradual progression: The hearing loss in DFNA47 tends to progress gradually over time, rather than occurring suddenly or abruptly.
It's worth noting that the characteristics of autosomal dominant nonsyndromic deafness 47 can vary from person to person, and not all individuals with this condition may exhibit these specific signs and symptoms. Additionally, the exact genetic cause of DFNA47 is not well-defined, which can make it challenging to predict or diagnose.
References:
- [7] Autosomal dominant non-syndromic sensorineural deafness 15 (DFNA15) is caused by heterozygous mutations in the POU4F3 gene on chromosome 5q32. However, this information may not be directly relevant to DFNA47.
- [10] Mutations in at least 30 genes have been identified in people with autosomal dominant nonsyndromic hearing loss; however, the specific genetic cause of DFNA47 is not mentioned here.
Please keep in mind that these points are based on a limited understanding of the condition and may not be comprehensive or entirely accurate. If you're looking for more detailed information, it's recommended to consult with a medical professional or a genetics expert.
Diagnostic Tests
Autosomal dominant nonsyndromic deafness (ADNSHL) is a form of hearing loss that is inherited in an autosomal dominant pattern, meaning that a single copy of the mutated gene is enough to cause the condition. Diagnostic tests for ADNSHL typically involve genetic testing and evaluation by medical professionals with expertise in genetics and hearing loss.
Common diagnostic tests for ADNSHL:
- Genetic testing: This involves analyzing DNA samples from affected individuals or family members to identify mutations in genes associated with ADNSHL, such as GJB2, SLC26A4, and MYO7A [1][3].
- Family studies: Evaluating the medical history of family members can help identify patterns of inheritance and confirm a diagnosis of ADNSHL [8].
- Gene panel testing: This involves analyzing multiple genes associated with hearing loss simultaneously to identify potential mutations [9].
Other diagnostic approaches:
- Clinical evaluation: A comprehensive clinical evaluation by a healthcare professional with expertise in genetics and hearing loss is essential for establishing a diagnosis of ADNSHL [6][10].
- Imaging studies: While imaging studies like CT scans may not detect malformations of the inner ear, they can be used to rule out other conditions that may cause hearing loss [7].
It's worth noting that the diagnostic yield for targeted familial testing was 60% (n = 3 patients) and for gene panel was 50% (n = 5), suggesting that these tests can be effective in identifying mutations associated with ADNSHL [9].
Additional Diagnostic Tests
- Clinical evaluation
- Genetic testing
- Imaging studies
- Gene panel testing
- Family studies
Treatment
Autosomal dominant nonsyndromic deafness refers to a type of hearing loss that is inherited in an autosomal dominant pattern, meaning that a single copy of the mutated gene is enough to cause the condition.
Current Treatment Options:
- Cochlear implants or hearing aids can improve auditory function in some patients [3].
- However, these treatments may not be sufficient for severe-to-profound hearing loss [6].
Emerging Therapies:
- Gene therapy is being researched as a potential treatment option for autosomal dominant nonsyndromic deafness. The goal of gene therapy is to directly address the primary cause of hearing loss (DNA mutations) [7].
Important Note: Consult with a healthcare professional for medical advice and treatment, as they can provide personalized guidance based on individual circumstances.
References: [3] - Current clinical treatments for HHL are cochlear implants or hearing aids, which can improve auditory function in some patients. [6] - For children with severe-to-profound HL, hearing aids may be insufficient for HL rehabilitation, and cochlear implantation should be considered. Cochlear implantation is a surgical procedure that involves implanting an electronic device into the ear to bypass damaged or non-functioning parts of the ear. [7] - With gene therapy, the goal is to directly address the primary cause of hearing loss (DNA mutations).
Recommended Medications
- Hearing aids
- Gene therapy
- Cochlear implants
💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.
Differential Diagnosis
Autosomal dominant nonsyndromic deafness (ADND) can be challenging to diagnose, as it often presents with similar symptoms to other hearing loss conditions. However, a differential diagnosis is essential to rule out other potential causes and provide an accurate diagnosis.
Possible Differential Diagnoses:
- Sporadic cases: Some individuals may experience autosomal dominant nonsyndromic deafness without a family history of the condition.
- Other genetic forms of hearing loss: Conditions like Usher syndrome, Pendred syndrome, or Connexin 26 mutations can present with similar symptoms to ADND.
- Environmental factors: Exposure to loud noises, certain medications, or infections can cause temporary or permanent hearing loss.
- Syndromic hearing loss: Certain genetic
Additional Differential Diagnoses
- Environmental factors
- Syndromic hearing loss
- Other genetic forms of hearing loss
- Sporadic cases
Additional Information
- oboInOwl#hasOBONamespace
- disease_ontology
- oboInOwl#hasDbXref
- MIM:608652
- oboInOwl#id
- DOID:0110570
- core#notation
- DOID:0110570
- IAO_0000115
- An autosomal dominant nonsyndromic deafness that has_material_basis_in variation in the chromosome region 9p22-p21.
- oboInOwl#hasExactSynonym
- DFNA47
- rdf-schema#label
- autosomal dominant nonsyndromic deafness 47
- rdf-schema#subClassOf
- http://purl.obolibrary.org/obo/DOID_0050564
- relatedICD
- http://example.org/icd10/H90.3
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_symptom_4924
- owl#annotatedSource
- t369946
Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.
It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.